Kigabeq
Active substance: vigabatrin
vigabatrin
Centralised EU authorisationActive
Marketing holder: Orphelia Pharma S.A.S.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 24 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5b84-777b-8d82-d6b9f0b33b5e,01a1208c-b27e-7625-99b5-df5637e258c0,01a1208d-82bd-7a62-a5b5-794c91732880,01a1208e-9249-71bd-bedf-5ea848f5f788,01a1208e-c519-76d9-aad6-945749a2c2e4;count=24 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004534
- Registration status
- Active
- ATC code
- N03AG04
Sources
- product · EMA · EMEA/H/C/004534 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004534 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004534 · Verified 2026-10-09